Whats a nice MBA like you doing in a place like pharmacogenomics?
Kellogg has quickly repositioned itself to meet the demand for managers to navigate this brave new business world. In June, Dean Donald Jacobs approached NUCB with a proposal to combine programs under the Kellogg umbrella and thereby set the standard for all other schools. A deal was soon hammered out and a curriculum established. The unique 14-course major will launch in fall 2001, as will a parallel biotech program designed to meet the needs of Kellogg’s Executive Education clientele. A field research component similar to TEK Venture is also in the works to provide students with a hands-on experience. Jacobs is frank about the business school’s approach to innovation. “Some have said — correctly, I think — that Kellogg turns on a dime,” notes Jacobs. “We are always chasing change. Our biotechnology initiative is an attempt to beat the wave, to be there as the wave crests, instead of chasing it. Biotech is the next big opportunity that will demand our interaction, causing us to chan
